Search Results

There are 4280 results for: content related to: The next step for taribavirin

  1. You have free access to this content
    Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1208–1215, Fred Poordad, Eric Lawitz, Mitchell L. Shiffman, Tarek Hassanein, Andrew J. Muir, Bruce R. Bacon, Jamie Heise, Deanine Halliman, Eric Chun and Janet Hammond

    Version of Record online : 30 JUN 2010, DOI: 10.1002/hep.23827

  2. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  3. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. Direct-acting antivirals for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz and Christian Gluud

    Published Online : 6 JUN 2017, DOI: 10.1002/14651858.CD012143.pub2

  6. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  7. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  8. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  9. You have full text access to this OnlineOpen article
    Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 4, August 2012, Pages: 370–378, M. Palmer, R. Rubin, V. Rustgi and Taribavirin Viral Kinetic Study Group

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1365-2036.2012.05188.x

  10. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  11. Relative blood volume measurements during hemodialysis: Comparisons between three noninvasive devices

    Hemodialysis International

    Volume 11, Issue 4, October 2007, Pages: 448–455, Judith J. DASSELAAR, Roel M. HUISMAN, Paul E. DE JONG and Casper F.M. FRANSSEN

    Version of Record online : 5 OCT 2007, DOI: 10.1111/j.1542-4758.2007.00216.x

  12. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  13. You have full text access to this OnlineOpen article
    Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate-activated protein kinase-related kinases and retinoid X receptor α

    Hepatology Communications

    Volume 1, Issue 6, August 2017, Pages: 550–563, Shinya Satoh, Kyoko Mori, Daichi Onomura, Youki Ueda, Hiromichi Dansako, Masao Honda, Shuichi Kaneko, Masanori Ikeda and Nobuyuki Kato

    Version of Record online : 13 JUL 2017, DOI: 10.1002/hep4.1065

  14. The RBV theory foundation of strategic HRM: critical flaws, problems for research and practice, and an alternative economics paradigm

    Human Resource Management Journal

    Volume 25, Issue 4, November 2015, Pages: 516–540, Bruce E. Kaufman

    Version of Record online : 24 SEP 2015, DOI: 10.1111/1748-8583.12085

  15. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  16. Therapy for hepatitis C genotype 3: moving forward

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 683–690, M. Buti, J. Llaneras, M. Riveiro-Barciela and R. Esteban

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvh.12419

  17. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy

    Journal of Medical Virology

    Volume 88, Issue 10, October 2016, Pages: 1776–1784, Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Masahide Oshita, Akira Kaneko, Hideki Hagiwara, Eiji Mita, Toshifumi Ito, Yukinori Yamada, Masami Inada, Kazuhiro Katayama, Shinji Tamura, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 29 MAR 2016, DOI: 10.1002/jmv.24528

  18. Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 9, September 2012, Pages: 1461–1466, Hideyuki Nomura, Yugo Miyagi, Hironori Tanimoto, Nobuyuki Yamashita, Kiyoaki Ito, Naohiko Masaki and Masashi Mizokami

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1440-1746.2012.07171.x

  19. Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 15, Issue 9, September 2008, Pages: 623–633, M. Gambarin-Gelwan and I. M. Jacobson

    Version of Record online : 10 JUL 2008, DOI: 10.1111/j.1365-2893.2008.01018.x

  20. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950